Navigation Links
Broad Institute Acquires License to all ChemAxon products and Deploys Across Chemical Biology Platform
Date:8/19/2010

Broad Institute Acquires License to all ChemAxon products and Deploys... -- BUDAPEST, Hungary and CAMBRIDGE, Massachusetts, August 19, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Computer Software, Biotechnology, Chemical, Contracts, Joint Ventures, Licensing Click to view news release full screen  

Broad Institute Acquires License to all ChemAxon products and Deploys Across Chemical Biology Platform

 

BUDAPEST, Hungary and CAMBRIDGE, Massachusetts, August 19, 2010 /PRNewswire/ --

- Compound Registration, Structure Search and Computed Properties Rolled Out

ChemAxon, a leading provider of chemistry software for life sciences, announced today that they have entered into an agreement with the Broad Institute of Harvard and MIT, which will license ChemAxon's platform, discovery toolkits and desktop applications for institute-wide use. Broad will support their legacy small molecule registration system and other functionality across their Chemical Biology Platform with ChemAxon's technology.

In addition to ChemAxon's discovery and desktop tools, the Broad Institute has already updated their core technology for archiving small molecules by deploying the JChem platform toolkit within their existing system.

"This adoption is a part of our strategy to provide our scientists in the Chemical Biology Platform with the most modern and capable tools to accelerate our research," said Michael Foley, Director of the Broad's Chemical Biology Platform. "The extensive capabilities of the ChemAxon software support our ongoing efforts to build and apply state of the art facilities to support our work."

The evaluation and deployment is to be presented during ChemAxon's User Group Meeting being held in Boston's Omni Parker House, September 14-15, the complete program is here: http://www.chemaxon.com/events/2010-us-ugm/

About ChemAxon

ChemAxon is a leader in providing cheminformatics software development platforms and applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. For more information please visit http://www.chemaxon.com.


'/>"/>
SOURCE ChemAxon Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
2. China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base
3. Bayer Broadens Its Manufacturing Basis for Biopharmaceuticals in Tobacco Plants
4. Nomad Bioscience Announces Broad License Agreement
5. GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
6. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
7. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
8. Biotech Drops on Weaker First Quarter Drug Sales, But Broader Markets Remain on a Roll
9. Gene Network Sciences Announces Broad Cancer Collaboration With UCSF and Initial Results
10. Boston Scientifics SpyGlass(R) Direct Visualization System Featured in Broad Range of Clinical Studies at Upcoming Digestive Disease Week(R)
11. NeoStem, Inc. Appoints Financial Expert with Broad International Experience to the Board of Directors and to Serve as Chairman of the Companys Audit Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Research Triangle Park, NC (PRWEB) , ... March ... ... drug development company engaged in the development of a new orally administered treatment ... Company’s Advisory Board. , CEO John Didsbury states, “As we seek to uniquely ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... produce small, heterogeneous samples with limited tumor content in a large background of ... resolved, such as the need for reliable detection of low abundance somatic mutations, ...
(Date:3/27/2017)... ... March 27, 2017 , ... PMG Research ... (CTC) conference presented by The Conference Forum in Boston on April 3-4, 2017. ... to drive improved clinical trial outcomes and bring them closer to the patient. Clinical ...
(Date:3/24/2017)... Ga. , March 24, 2017 MiMedx ... biopharmaceutical company utilizing human placental tissue allografts and patent-protected ... for multiple sectors of healthcare, announced today  that it ... New York , NY.  Parker H. "Pete" ... Chief Financial Officer, Christopher M. Cashman , EVP ...
Breaking Biology Technology:
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. Mohamed Anwar ... the prestigious international IAIR Award for the most innovative high security ePassport ... ... Maldives Immigration Controller General, Mr. ... on the right) have received the IAIR award for the "Most innovative ...
(Date:3/23/2017)... , Mar. 23, 2017 Research and Markets ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 8.8% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
(Date:3/22/2017)... LIVERMORE, Calif. , March 21, 2017 ... recognition analytics company serving law enforcement agencies, announced today ... Sheridan as director of public safety business development. ... of diversified law enforcement experience, including a focus on ... Vigilant. In his most recent position, Mr. Sheridan served ...
Breaking Biology News(10 mins):